Monoclonal antibodies against the PB1-F2 protein of H1N1 influenza a virus

Hybridoma

Volumn 29, Issue 4, 2010, Pages 321-326

  Nordmann, Alexandra ^a   Wixler, Ludmilla ^a   Ludwig, Stephan ^a   Wixler, Viktor ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY F2 6G10; PROTEIN PB1 F2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HYBRIDOMA; IMMUNODETECTION; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; INFLUENZA VIRUS A H1N1; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; CELLS, CULTURED; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; HELA CELLS; HUMANS; HYBRIDOMAS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; IMMUNOPRECIPITATION; KIDNEY; MICE; MICE, INBRED BALB C; NIH 3T3 CELLS; RECOMBINANT PROTEINS; VIRAL PROTEINS;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 77955883390     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2010.0010     Document Type: Article

References (10)

1. Neumann G, Brownlee GG, Fodor G, and Kawaoka Y: Orthomyxovirus replication, transcription, and polyadenylation. Curr Top Microbiol Immunol 2004;283:121-143.
2. Gabriel G, Dauber B, Wolff T, Planz O, Klenk HD, and Stech J: The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci USA 2005;102:18590-18595.
3. Digard P, Blok VC, and Inglis SC: Complex formation between influenza virus polymerase proteins expressed in Xenopus oocytes. Virology 1989;171:162-169.
4. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, Basta S, O'Neill R, Schickli J, Palese P, Henklein P, Bennink JR, and Yewdell JW: A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 2001;7:1306-1312.
5. Mazur I, Anhlan D, Mitzner D, Wixler L, Schubert U, and Ludwig S: The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol 2008;10:1140-1152.
6. Zamarin D, Garcia-Sastre A, Xiao X, Wang R, and Palese P: Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog 2005;1:e4.
7. McAuleyJL, Hornung F, Boyd KL, Smith AM, McKeon R, Bennink J, Yewdell JW, and McCullers JA: Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2007;2:240-249.
8. Mitzner D, Dudek SE, Studtrucker N, Anhlan D, Mazur I, Wissing J, Jansch L, Wixler L, Bruns K, Sharma A, Wray A, Henklein P, Ludwig S, and Schubert U: Phosphorylation of the influenza A virus protein PB1-F2 by PKC is crucial for apoptosis promoting functions in monocytes. Cell Microbiol 2009;11:1502-1516.
9. Conenello GM, Zamarin D, Perrone LA, Tumpey T, and Palese P: A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 2007;3:1414-1421.
10. Basler CF, Wang X, Muhlberger E, Volchkov V, Paragas J, Klenk HD, Garcia-Sastre A, and Palese P: The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci USA 2000;97:12289-12294.